Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Drug Safety / Springer


0.13

Impact Factor

0.13

5-Years IF

2

5-Years H index

Main indicators


Raw data


IF AIF IF5 DOC CDO CCU CIF CIT D2Y C2Y D5Y C5Y %SC CiY II AII
19900.1000 (%)0.04
19910.09000 (%)0.04
19920.09000 (%)0.04
19930.1000 (%)0.05
19940.11000 (%)0.05
19950.2000 (%)0.07
19960.23000 (%)0.09
19970.27000 (%)0.09
19980.29000 (%)0.1
19990.32000 (%)0.13
20000.4000 (%)0.15
20010.4000 (%)0.15
20020.42000 (%)0.18
20030.44000 (%)0.19
20040.49000 (%)0.2
20050.53000 (%)0.21
20060.51000 (%)0.2
20070.45000 (%)0.18
20080.48000 (%)0.2
20090.47000 (%)0.19
20100.45000 (%)0.16
20110.52000 (%)0.2
20120.55000 (%)0.2
20130.62000 (%)0.22
20140.64885005 (100%)0.21
20150.69888 (%)0.22
20160.130.850.13109117120.117818115 (88.2%)70.060.26
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CCU: Cumulative number of citations to papers published until year y
CIF: Cumulative impact factor
CIT: Number of citations to papers published in year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y

 

50 most cited documents in this series:


#YearTitleCited
12014Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Callahan, Alison ; Low, Yen ; Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

3
22014Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. (2014). Lindquist, Marie ; Bate, Andrew ; Tuccori, Marco ; Hartigan-Go, Kenneth ; Beckmann, Jurgen ; McEwen, John ; Moride, Yola ; Wong, Ian ; Hagemann, Ulrich ; Boyd, Ian ; Olsson, Sten ; Edwards, I. ; Pal, Shanthi ; Pan, Gerald Dal ; Soulaymani-Bencheikh, Rachida ; Vaca, Claudia ; Bahri, Priya . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:743-759.

Full description at Econpapers || Download paper

2
32016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

2
42017Comment on: Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2017). Lapeyre-Mestre, Maryse ; Ponte, Camille ; Jouanjus, Emilie ; Mallaret, Michel ; Micallef, Joelle ; Roussin, Anne . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:2:d:10.1007_s40264-016-0497-7.

Full description at Econpapers || Download paper

1
52016Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives. (2016). Comuth, Willemijn J ; Husted, Steen . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0357-x.

Full description at Econpapers || Download paper

1
62016Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?. (2016). Slattery, Jim . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-016-0407-z.

Full description at Econpapers || Download paper

1
72016Comment on: “Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence”. (2016). Braillon, Alain . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0447-4.

Full description at Econpapers || Download paper

1
82016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Sarker, Abeed ; Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

1
92016Drug Interactions of Direct-Acting Oral Anticoagulants. (2016). Fitzgerald, John Leonard ; Howes, Laurence Guy . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0443-8.

Full description at Econpapers || Download paper

1
102016The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. (2016). Garbe, Edeltraut ; Pariente, Antoine ; Koci, Ariola ; Salvo, Francesco ; Moretti, Ugo ; Hazell, Lorna ; Perina, Luisella ; Ponti, Fabrizio ; Antoniazzi, Stefania ; Sturkenboom, Miriam ; Raschi, Emanuel ; Suling, Marc ; Poluzzi, Elisabetta . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0353-1.

Full description at Econpapers || Download Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A ; Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper

1
122017Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice. (2017). Stocks, Jill S ; Ashcroft, Darren M ; Burns, Alistair ; Avery, Anthony J ; Webb, Roger T ; Kontopantelis, Evangelos . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0538-x.

Full description at Econpapers || Download paper

1
132016A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases. (2016). Tubert-Bitter, Pascale ; Robinson, Philip ; Salvo, Francesco ; Arnaud, Mickael ; Begaud, Bernard ; Moore, Nicholas ; Ahmed, Ismail ; Pariente, Antoine . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0375-8.

Full description at Econpapers || Download paper

1
142016Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature. (2016). Sarges, Philip ; Lewis, James H ; Steinberg, Joshua M. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0427-8.

Full description at Econpapers || Download paper

1
152016Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records. (2016). Hripcsak, George ; Dumontier, Michel ; Shah, Nigam Haresh ; Vilar, Santiago ; Banda, Juan M ; Callahan, Alison ; Winnenburg, Rainer ; Reis, Ben Y ; Cami, Aurel ; Strasberg, Howard R. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0352-2.

Full description at Econpapers || Download paper

1
162016Comment on ‘The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project’. (2016). Braillon, Alain . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-016-0403-3.

Full description at Econpapers || Download paper

1
172017Using Probabilistic Record Linkage of Structured and Unstructured Data to Identify Duplicate Cases in Spontaneous Adverse Event Reporting Systems. (2017). Kreimeyer, Kory ; Botsis, Taxiarchis ; Forshee, Richard ; Zinderman, Craig ; Arya, Deepa ; Alimchandani, Meghna ; Woo, Emily Jane ; Barash, Faith ; Paul, Wendy ; Winiecki, Scott ; Menschik, David . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0523-4.

Full description at Econpapers || Download Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports. (2016). Klein, Kevin ; Puijenbroek, Eugene P ; Broekmans, Andre W ; Stolk, Pieter ; Bruin, Marie L ; Vermeer, Niels S. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0383-8.

Full description at Econpapers || Download paper

1
192016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Rolfes, Lean ; Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

1
202016An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies. (2016). MacIa-Martinez, Miguel-Angel ; Roberts, Gilly ; Abajo, Francisco J ; Thakrar, Bharat ; Antoni, ; Slattery, Jim . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0351-3.

Full description at Econpapers || Download paper

1
212016Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G ; Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3.

Full description at Econpapers || Download paper

1
222017Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification. (2017). Onakpoya, Igho J ; Aronson, Jeffrey K ; Heneghan, Carl J. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0515-4.

Full description at Econpapers || Download paper

1
232014Pharmacovigilance in China: Current Situation, Successes and Challenges. (2014). Wong, Ian ; He, Ying ; Zhang, LI. In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:765-770.

Full description at Econpapers || Download paper

1
242016What Is the Plural of a ‘Yellow’ Anecdote?. (2016). Stephen, . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0368-7.

Full description at Econpapers || Download paper

1
252016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Tregunno, Phil ; Antoni, ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download Estimating Herbal Product Authentication and Adulteration in India Using a Vouchered, DNA-Based Biological Reference Material Library. (2016). Ragupathy, Subramanyam ; Sathishkumar, Ramalingam ; Shanmughanandhan, Dhivya ; Mohanasundaram, Saravanan ; Newmaster, Steven G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0459-0.

Full description at Econpapers || Download paper

1
272016Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology. (2016). Pinheiro, Simone P ; Greene, Patty ; Hampp, Christian . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0382-9.

Full description at Econpapers || Download paper

1

50 most relevant documents in this series (papers most cited in the last two years)


#YearTitleCited
12014Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Callahan, Alison ; Low, Yen ; Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

3
22014Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. (2014). Lindquist, Marie ; Bate, Andrew ; Tuccori, Marco ; Hartigan-Go, Kenneth ; Beckmann, Jurgen ; McEwen, John ; Moride, Yola ; Wong, Ian ; Hagemann, Ulrich ; Boyd, Ian ; Olsson, Sten ; Edwards, I. ; Pal, Shanthi ; Pan, Gerald Dal ; Soulaymani-Bencheikh, Rachida ; Vaca, Claudia ; Bahri, Priya . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:743-759.

Full description at Econpapers || Download paper

2
32016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

2

Citing documents used to compute impact factor 1:


YearTitle
2016Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Ampadu, Haggar H ; Sartori, Daniele ; Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4.

Full description at Econpapers || Download paper

Recent citations (cites in year: CiY)


Recent citations received in 2016

YearCiting document
2016Authors’ Reply to Alain Braillon’s Comment on “Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence”. (2016). Chambers, Sophia E ; Baldwin, David S. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0448-3.

Full description at Econpapers || Download paper

2016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Harmark, Linda ; Matos, Cristiano ; Hunsel, Florence . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

2016A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Grampp, Gustavo ; Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

2016On Designs for Vaccine Surveillance. (2016). Platt, Robert W. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0457-2.

Full description at Econpapers || Download paper

2016Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. (2016). Raschi, Emanuel ; de Ponti, Fabrizio ; Ageno, Walter ; Bianchin, Matteo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0464-3.

Full description at Econpapers || Download paper

2016Authors’ Reply to Alain Braillon’s Comment on “The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project”. (2016). Raschi, Emanuel ; Ponti, Fabrizio ; Poluzzi, Elisabetta ; Salvo, Francesco ; Moretti, Ugo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-016-0404-2.

Full description at Econpapers || Download paper

2016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Tregunno, Phil ; Antoni, ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download

Recent citations received in 2014

YearCiting document

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 1st 2017. Contact: CitEc Team